By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
Mentice AB (publ) initiates the recruitment of new CEO
Read more
Mentice has received a 2.26 million USD order for simulation solutions from a top 20 global MedTech company
Read more

Mentice Investors

Our solutions help improve patient outcomes and clinical performance one therapy-one patient at a time.

About Mentice
For almost a quarter of a century, Mentice has been at the forefront of solutions that support IGIT (Image-guided Interventional Therapies*) revolutionizing minimally invasive interventional procedures workflows with our global partners. Mentice has moved from being a supplier of endovascular simulation to a provider of IGIT performance solutions.

More than 3100+ Mentice systems, hundreds of industry led development projects and thousands of consumables have been delivered to Mentice Business Areas; the Medical Device industry (MDI), Healthcare systems (HCS), and Strategic Alliance (SA) partners globally.

To learn more about how Mentice strives to address global healthcare challenges, please visit


Trading information
Short name for Nasdaq First North Growth Market : MNTC

ISIN-code: SE0012673291

The shares are registered by Euroclear Sweden AB

FNCA Sweden AB is the Certified Advisor for the company

Important information about Nasdaq First North Growth Market Nasdaq
First North Growth Market is an alternate trading platform managed as a separate organization within NASDAQ Group. Companies listed on Nasdaq First North Growth Market is not managed under the same set of rules as the regulated main list market. The companies follow less complex set of rules and procedures adapted for small growth companies. The risk involved with investment in companies on First North Growth market can therefore be higher than investing in companies on the main market. All companies with shares that is traded on Nasdaq First North Growth Market has a certified advisor that secure and control that the rules are followed.


Financial targets (short-medium term)

Revenue Growth
20-30% annual growth in Net sales during mid-term (three years)

EBITDA margin in the mid-term (three years) of 20 per cent with a longer-term target of 30 per cent EBITDA margin.

Dividend Policy
Mentice is a company on a rapidly growing market. To capitalize on its market opportunities, the company will prioritize growth, both organic and through acquisitions.


The company has no history of Dividend.

Financial Calendar




Q4 Interim Report OCT-DEC 2023




Capital Markets Day




Q1 Interim Report JAN- MAR 2024




Annual General Meeting 2024




Q2 Interim Report APR - JUN




Q3 Interim Report JUL - SEPT 2024